Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies - Concentration of revenue (Details)

v3.22.2.2
Significant Accounting Policies - Concentration of revenue (Details) - USD ($)
3 Months Ended
Dec. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Concentration Risk [Line Items]      
Financial Designation, Predecessor and Successor [Fixed List] Successor Successor Predecessor
Total Revenue by Year   $ 273,544,334 $ 151,297,940
Revenue | Customer Concentration      
Concentration Risk [Line Items]      
Total Revenue by Year   $ 273,544,334 $ 151,297,940
Percentage of total revenue   100.00% 100.00%
Health Plan A | Revenue | Customer Concentration      
Concentration Risk [Line Items]      
Total Revenue by Year   $ 45,238,065 $ 43,254,924
Percentage of total revenue   16.50% 28.60%
Health Plan B | Revenue | Customer Concentration      
Concentration Risk [Line Items]      
Total Revenue by Year   $ 48,019,382 $ 33,952,002
Percentage of total revenue   17.60% 22.50%
Health Plan C | Revenue | Customer Concentration      
Concentration Risk [Line Items]      
Total Revenue by Year   $ 55,321,176 $ 19,280,237
Percentage of total revenue   20.20% 12.70%
Health Plan D | Revenue | Customer Concentration      
Concentration Risk [Line Items]      
Total Revenue by Year   $ 36,862,961 $ 27,694,259
Percentage of total revenue   13.50% 18.30%
All Other | Revenue | Customer Concentration      
Concentration Risk [Line Items]      
Total Revenue by Year   $ 88,102,750 $ 27,116,518
Percentage of total revenue   32.20% 17.90%